Hepcidin promotes osteogenic differentiation through the bone morphogenetic protein 2/small mothers against decapentaplegic and mitogen-activated protein kinase/P38 signaling pathways in mesenchymal stem cells

The ability of mesenchymal stem cells (MSCs) to differentiate into osteogenic lineages requires management for their future use in treating bone destruction and osteoporosis. Hepcidin is closely associated with bone metabolism, however, it remains to be elucidated whether hepcidin affects osteogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: LU, HUADING, LIAN, LIYI, SHI, DEHAI, ZHAO, HUIQING, DAI, YUHU
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237087/
https://www.ncbi.nlm.nih.gov/pubmed/25351366
http://dx.doi.org/10.3892/mmr.2014.2769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237087/
https://www.ncbi.nlm.nih.gov/pubmed/25351366
http://dx.doi.org/10.3892/mmr.2014.2769

Ejemplares similares